跳至主要内容
临床试验/ISRCTN41024033
ISRCTN41024033已完成不适用

Myeloid Leukaemia Down Syndrome 2006 for the treatment of myeloid leukaemia in children with Down syndrome: a multicentre, open-label, non-randomised trial with direct individual benefit

niversity of Münster (Germany)0 个研究点目标入组 150 人开始时间: 2009年3月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Children with trisomy 21/trisomy 21 mosaic and myeloid leukaemia
  • 2. Aged greater than 6 months to 4 years of age with/without GATA1 mutation, or aged greater than 4 years of age to 18 years of age with GATA1 mutation, either sex
  • 3. Patients, in the above age group, must have DS and ML
  • 4. Written informed consent

排除标准

  • 1. Children without DS
  • 2. Children with DS and transient myeloproliferative disorder (TMD)
  • 3. Children with DS and acute lymphoblastic leukaemia (ALL)
  • 4. Accompanying diseases which do not allow therapy according to the protocol
  • 5. Pre-treatment greater than 14 days with intensive induction therapy

研究者

发起方
niversity of Münster (Germany)

相似试验